{"id":1976,"date":"2024-06-18T14:08:01","date_gmt":"2024-06-18T14:08:01","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1976"},"modified":"2026-02-22T23:06:52","modified_gmt":"2026-02-22T23:06:52","slug":"intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/","title":{"rendered":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked)"},"content":{"rendered":"

Neurodevelopmental disorders (NDDs) affect brain development and function, with varying symptoms and genetic causes. While some RAS superfamily proteins are known to contribute to NDDs, the role of SGSM (small G protein signaling modulator) remained unexplored. A recent study changed that, identifying an SGSM3 gene founder variant in 13 patients from 8 Ashkenazi Jewish families. This variant, shared by all affected members, likely impairs SGSM3 function, causing mild developmental delays, intellectual challenges, hypotonia, behavioral issues, and short stature. This discovery adds SGSM3 to the list of genes associated with NDDs, opening new avenues for research into its role in brain development and growth regulation. It is also expected to allow the diagnosis of dozens of undiagnosed Ashkenazi Jews individuals with NDD. (https:\/\/jmg.bmj.com\/content\/61\/3\/289<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Neurodevelopmental disorders (NDDs) affect brain development and function, with varying symptoms and genetic causes. While some RAS superfamily proteins are known to contribute to NDDs, the role of SGSM (small G protein signaling modulator) remained unexplored. A recent study changed that, identifying an SGSM3 gene founder variant in 13 patients from 8 Ashkenazi Jewish families. […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1976","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nIntellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Neurodevelopmental disorders (NDDs) affect brain development and function, with varying symptoms and genetic causes. While some RAS superfamily proteins are known to contribute to NDDs, the role of SGSM (small G protein signaling modulator) remained unexplored. A recent study changed that, identifying an SGSM3 gene founder variant in 13 patients from 8 Ashkenazi Jewish families. [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-18T14:08:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-22T23:06:52+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked)\",\"datePublished\":\"2024-06-18T14:08:01+00:00\",\"dateModified\":\"2026-02-22T23:06:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/\"},\"wordCount\":143,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/\",\"name\":\"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2024-06-18T14:08:01+00:00\",\"dateModified\":\"2026-02-22T23:06:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2024\\\/06\\\/18\\\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/","og_locale":"en_US","og_type":"article","og_title":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog","og_description":"Neurodevelopmental disorders (NDDs) affect brain development and function, with varying symptoms and genetic causes. While some RAS superfamily proteins are known to contribute to NDDs, the role of SGSM (small G protein signaling modulator) remained unexplored. A recent study changed that, identifying an SGSM3 gene founder variant in 13 patients from 8 Ashkenazi Jewish families. [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/","og_site_name":"JMG Contact blog","article_published_time":"2024-06-18T14:08:01+00:00","article_modified_time":"2026-02-22T23:06:52+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked)","datePublished":"2024-06-18T14:08:01+00:00","dateModified":"2026-02-22T23:06:52+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/"},"wordCount":143,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/","url":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/","name":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2024-06-18T14:08:01+00:00","dateModified":"2026-02-22T23:06:52+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2024\/06\/18\/intellectual-disability-syndrome-associated-with-a-homozygous-founder-variant-in-sgsm3-in-ashkenazi-jews\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews (Contributed by Dr. Hagar Mor-Shaked)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1976"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1976\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}